median age, 59 years) 194 were prescribed semaglutide and 516 were prescribed a non-GLP-1 medication
These are the same inflammatory mediators that drive disease activity in rheumatoid arthritis , lupus, psoriasis, and inflammatory bowel disease
The best option for you depends on your weight-loss goals, response to treatment, and how well you tolerate the medication
Hypersensitivity Reactions: Severe, life-threatening, generalized allergy, including anaphylaxis, may occur with insulin products, including NovoLog
Harnessing the body's natural mechanisms, Tirzepatide supports effective weight management by optimizing insulin and glucose levels